The FDA Just Approved a First-Of-Its-Kind Drug That Targets Cancer’s Genes

• Keytruda, a new immunotherapy drug used to treat solid cancers that display a particular biomarker, just received FDA approval.
• Along with other cutting-edge cancer treatments, this represents a focus on genetics rather than location of the tumor in treatment and prevention.

https://futurism.com/the-fda-just-approved-a-first-of-its-kind-drug-that-targets-cancers-genes/